NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 383 filers reported holding NEKTAR THERAPEUTICS in Q2 2018. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $42,770 | -80.1% | 60,848 | -36.0% | 0.00% | -100.0% |
| Q4 2022 | $214,799 | -29.4% | 95,044 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $304,141 | -15.8% | 95,044 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $361,167 | +1766.0% | 95,044 | +2546.7% | 0.00% | – |
| Q1 2022 | $19,355 | -98.8% | 3,591 | -95.9% | 0.00% | -100.0% |
| Q3 2021 | $1,585,850 | +1.4% | 88,299 | -3.1% | 0.02% | 0.0% |
| Q2 2021 | $1,563,190 | -16.9% | 91,095 | -3.2% | 0.02% | -16.7% |
| Q1 2021 | $1,882,080 | +12.8% | 94,104 | -4.1% | 0.02% | +5.9% |
| Q4 2020 | $1,668,873 | -1.8% | 98,169 | -4.2% | 0.02% | -10.5% |
| Q3 2020 | $1,699,264 | -30.6% | 102,427 | -3.1% | 0.02% | -32.1% |
| Q2 2020 | $2,447,989 | +35.8% | 105,699 | +4.7% | 0.03% | +12.0% |
| Q1 2020 | $1,802,511 | -17.3% | 100,981 | 0.0% | 0.02% | +8.7% |
| Q4 2019 | $2,179,675 | +150.9% | 100,981 | +111.7% | 0.02% | +130.0% |
| Q3 2019 | $868,819 | -49.2% | 47,698 | -0.7% | 0.01% | -47.4% |
| Q2 2019 | $1,709,441 | +2.9% | 48,045 | -2.9% | 0.02% | 0.0% |
| Q1 2019 | $1,662,024 | +2.2% | 49,465 | -0.0% | 0.02% | -5.0% |
| Q4 2018 | $1,626,243 | -46.8% | 49,475 | -1.3% | 0.02% | -37.5% |
| Q3 2018 | $3,057,022 | +32.0% | 50,148 | +5.7% | 0.03% | +18.5% |
| Q2 2018 | $2,316,000 | -81.1% | 47,429 | -58.9% | 0.03% | -81.2% |
| Q1 2018 | $12,261,000 | +206.6% | 115,385 | +72.3% | 0.14% | +220.0% |
| Q4 2017 | $3,999,000 | – | 66,957 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TIRSCHWELL & LOEWY INC | 588,908 | $7,138,000 | 1.23% |
| Granahan Investment Management | 3,693,956 | $44,771,000 | 1.21% |
| NEA Management Company, LLC | 1,825,600 | $22,126,000 | 1.09% |
| FIC CAPITAL INC | 150,868 | $1,829,000 | 0.75% |
| Rhenman & Partners Asset Management AB | 181,797 | $2,203,000 | 0.66% |
| SOPHROSYNE CAPITAL LLC | 60,200 | $728,000 | 0.64% |
| HARVEY CAPITAL MANAGEMENT INC | 130,400 | $1,580,000 | 0.63% |
| Artal Group S.A. | 1,300,000 | $15,756,000 | 0.57% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 564,418 | $6,840,000 | 0.47% |
| OppenheimerFunds, Inc. | 24,400,000 | $295,728,000 | 0.35% |